Live
- 1 in 5 IT decision-makers struggling to find AI/ML talent: Report
- India's economy in sweet spot with strong growth, inflation likely to ease: Moody’s
- Mani Shankar Aiyar questions Jaishankar's visit to Pakistan, says he created 'false hope'
- K.T. Rama Rao calls on farmers arrested for attack on Vikarabad officials
- AP CM Chandrababu Naidu Unveils Vision for Andhra Pradesh amidst Financial Challenges
- VVS Laxman lauds fans for massive support on foreign tours
- Bengal lottery scam: Huge amount of cash traced, ED brings currency counting machine
- Raj Thackeray releases MNS election Manifesto with a ‘key’ to implementing it
- Gold prices likely to further come down with no near-term positive triggers
- Tough decision, but it's the right one: Southee on Test retirement
Visakhapatnam: Indian vaccine industry meets 60% of global requirement
CDSCO deputy drugs controller A Ramkishan addressing the faculty and students during the national conference held at the campus in Visakhapatnam on Friday
Central Drugs Standard Control Organisation official says 8 vaccine manufacturers of India are pre-qualified by the WHO for supply to UN agencies
Visakhapatnam : The Indian vaccine industry is meeting the requirements of 60 per cent of the global immunisation programme and 65 per cent of the children in the world are receiving Indian vaccines, ministry of health and family welfare Central Drugs Standard Control Organisation (CDSCO) deputy drugs controller A Ramkishan said.
Participating as distinguished guest in a national conference on ‘PharmaBuzz-2023’ organised by GITAM School of Pharmacy on the campus on Friday, he informed that around 21 bulk vaccines and 32 vaccine formulations were approved in India for human use to promote community health.
Also, Dr Ramkishan said that out of 21 human vaccine manufacturers in India, eight vaccine manufacturers are pre-qualified by the WHO for supply to UN agencies (43 vaccines in 88 formulations).
He said eight out of top 20 global generic companies are from India and about 300 large and over 10,000 SMEs in the Indian pharmaceutical sector contribute to 85 per cent of market branded generic medicines and exporting to 201 countries.
The CDSCO deputy drugs controller stated that the government is taking steps for improving transparency and accountability and promoting ethical and scientific clinical research and development of new drugs.
He observed that the government initiated Ayushman Bharat-National Health Protection Mission which is a cashless Aadhar-enabled facility, offering various health benefits to the poor.
Institute of Medical Sciences and Research (GIMSR) Pro Vice-Chancellor B.Gitanjali, Registrar D. Gunsekharan, School of Pharmacy Dean Jagattaran Das, Christ University (Bengaluru) Centre for Advanced Research and Development Director Gurumurthy Hegde, Aspire Scientific Director Subhendu Saha, among others participated in the discussions.
